Insufficient scRNA-seq data for expression of OXT at single-cell level.
Insufficient scRNA-seq data for expression of OXT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 99% | 168.87 | 223 / 226 | 35% | 5.97 | 144 / 406 |
kidney | 97% | 42.78 | 86 / 89 | 28% | 1.66 | 253 / 901 |
breast | 98% | 33.66 | 450 / 459 | 21% | 0.42 | 237 / 1118 |
thymus | 93% | 14.59 | 606 / 653 | 23% | 0.45 | 139 / 605 |
uterus | 86% | 10.84 | 146 / 170 | 26% | 0.76 | 121 / 459 |
esophagus | 58% | 5.27 | 837 / 1445 | 48% | 1.53 | 88 / 183 |
adrenal gland | 93% | 29.55 | 239 / 258 | 12% | 0.90 | 27 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.13 | 1 / 1 |
ovary | 52% | 6.81 | 93 / 180 | 43% | 1.11 | 185 / 430 |
adipose | 94% | 41.57 | 1136 / 1204 | 0% | 0 | 0 / 0 |
prostate | 90% | 15.90 | 221 / 245 | 4% | 0.07 | 19 / 502 |
intestine | 68% | 9.07 | 661 / 966 | 21% | 0.70 | 109 / 527 |
skin | 79% | 23.48 | 1433 / 1809 | 9% | 0.32 | 41 / 472 |
bladder | 71% | 9.67 | 15 / 21 | 15% | 0.32 | 75 / 504 |
brain | 80% | 3674.28 | 2120 / 2642 | 2% | 0.04 | 17 / 705 |
stomach | 40% | 3.33 | 142 / 359 | 40% | 1.78 | 114 / 286 |
lung | 46% | 4.12 | 266 / 578 | 24% | 1.03 | 282 / 1155 |
heart | 66% | 6.49 | 568 / 861 | 0% | 0 | 0 / 0 |
spleen | 64% | 5.32 | 154 / 241 | 0% | 0 | 0 / 0 |
pancreas | 16% | 1.37 | 52 / 328 | 32% | 0.67 | 57 / 178 |
peripheral blood | 44% | 4.16 | 407 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 40% | 0.89 | 18 / 45 |
blood vessel | 34% | 2.58 | 453 / 1335 | 0% | 0 | 0 / 0 |
muscle | 26% | 2.06 | 205 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.35 | 12 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.21 | 2 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042756 | Biological process | drinking behavior |
GO_0032355 | Biological process | response to estradiol |
GO_0007625 | Biological process | grooming behavior |
GO_0060450 | Biological process | positive regulation of hindgut contraction |
GO_0060406 | Biological process | positive regulation of penile erection |
GO_0043434 | Biological process | response to peptide hormone |
GO_0045777 | Biological process | positive regulation of blood pressure |
GO_0045925 | Biological process | positive regulation of female receptivity |
GO_0007507 | Biological process | heart development |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0007165 | Biological process | signal transduction |
GO_0060179 | Biological process | male mating behavior |
GO_0002027 | Biological process | regulation of heart rate |
GO_0042713 | Biological process | sperm ejaculation |
GO_0014823 | Biological process | response to activity |
GO_0007565 | Biological process | female pregnancy |
GO_0035811 | Biological process | negative regulation of urine volume |
GO_0002125 | Biological process | maternal aggressive behavior |
GO_0042220 | Biological process | response to cocaine |
GO_0051591 | Biological process | response to cAMP |
GO_0042711 | Biological process | maternal behavior |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0045776 | Biological process | negative regulation of blood pressure |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0009744 | Biological process | response to sucrose |
GO_0010701 | Biological process | positive regulation of norepinephrine secretion |
GO_0070474 | Biological process | positive regulation of uterine smooth muscle contraction |
GO_0042755 | Biological process | eating behavior |
GO_0034695 | Biological process | response to prostaglandin E |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0007613 | Biological process | memory |
GO_0032308 | Biological process | positive regulation of prostaglandin secretion |
GO_0032526 | Biological process | response to retinoic acid |
GO_0001975 | Biological process | response to amphetamine |
GO_0050806 | Biological process | positive regulation of synaptic transmission |
GO_0045472 | Biological process | response to ether |
GO_0032094 | Biological process | response to food |
GO_0035176 | Biological process | social behavior |
GO_0045778 | Biological process | positive regulation of ossification |
GO_0051965 | Biological process | positive regulation of synapse assembly |
GO_0032570 | Biological process | response to progesterone |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0043195 | Cellular component | terminal bouton |
GO_0030141 | Cellular component | secretory granule |
GO_0005185 | Molecular function | neurohypophyseal hormone activity |
GO_0031855 | Molecular function | oxytocin receptor binding |
GO_0031894 | Molecular function | V1A vasopressin receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0005184 | Molecular function | neuropeptide hormone activity |
Gene name | OXT |
Protein name | Oxytocin-neurophysin 1 (OT-NPI) [Cleaved into: Oxytocin (Ocytocin); Neurophysin 1] Oxytocin-neurophysin 1 |
Synonyms | hCG_39619 OT |
Description | FUNCTION: Neurophysin 1 specifically binds oxytocin.; FUNCTION: Oxytocin causes contraction of the smooth muscle of the uterus and of the mammary gland. Acts by binding to oxytocin receptor (OXTR) . . FUNCTION: Neurophysin 1 specifically binds oxytocin. . |
Accessions | P01178 ENST00000217386.2 X5D7M6 |